Loading stock data…
Bayer AG N (BAYN.DE)
€49.41-0.27 (-0.56%)
Market OpenUpdated 11:36 AM EDT
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Bayer Aktiengesellschaft in the Healthcare sector is trading at €49.41 with a market capitalization of $47.0B. Wall Street consensus targets €57.94 (18 analysts), implying a +17.3% move over the next 12 months. The stock is currently near its 52-week high of €53.92, remaining 19.6% above its 200-day moving average. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +17.3% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (EUR) | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Total Revenue | €10.74B↑ | €9.66B↓ | €11.44B↓ | €13.40B↑ | €10.87B |
| Gross Profit | €6.38B↑ | €5.35B↓ | €6.94B↓ | €8.17B↑ | €6.33B |
| Operating Income | €13.00M↑ | -€543.00M↓ | €4.34B↑ | €3.53B↑ | €827.00M |
| Net Income | -€199.00M↑ | -€963.00M↑ | -€3.76B↓ | €2.76B↑ | €219.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
€46.95B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.83
Div Yield
Strong income play. Yield provides a meaningful total return floor.
23.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-5.69%
Volume
Today's trading volume
316
Recent News
Corn and Soybean Prices Are Popping. How to Play It.
For investors, there are many ways to play commodities, including exchange-traded funds keyed off agricultural commodities and food-related stocks.
Bayer Crop Science Targets €3B Cash Flow by 2029 With Seeds-Led Growth
Bayer Aktiengesellschaft (ETR:BAYN) outlined progress on its Crop Science division’s five-year framework at a 2026 innovation event in Iowa, reaffirming targets for above-market sales growth, a mid-20s clean EBITDA margin and more than €3 billion in free operating cash flow by 2029. Rodrigo Santos,
Bayer (XTRA:BAYN) Just Gave Investors Something To Think About
Bayer (XTRA:BAYN) is back in focus after detailed Phase III REVEAL data for its investigational PET radiotracer iodine 124 evuzamitide in cardiac amyloidosis were presented, meeting predefined diagnostic accuracy endpoints. The REVEAL data arrive after a period of strong share price momentum for Bayer, with the 90 day share price return of 40.86% and year to date share price return of 28.63%, which contrasts with a three year total shareholder return that is slightly negative. Extend this...
Sector Update: Healthcare Stocks Decline Late Afternoon
Healthcare stocks were lower late Monday afternoon, with the NYSE Healthcare Index decreasing 0.5% a
Bayer's $7.25 Billion Roundup Plan Survives Another Court Detour
The federal challenge is gone, but the settlement still faces a decisive Missouri hearing.